A multidisciplinary approach in patients with femoral neck fracture on an osteoporotic basis.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 21103630)

Published in Rom J Morphol Embryol on January 01, 2010

Authors

Diana Drăgoi1, Roxana Popescu, Rodica Trăistaru, Daniela Matei, Alina Mihaela Buzatu, Nina Ionovici, D Grecu

Author Affiliations

1: Department of Physical Medicine and Rehabilitation, Emergency County Hospital, Craiova, Romania. di_ule@yahoo.com

Articles by these authors

Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res (2008) 6.38

Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med (2012) 5.31

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res (2002) 3.64

Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. J Clin Oncol (2006) 1.65

Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res (2009) 1.39

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Cancer Res (2007) 1.29

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis (2008) 1.24

Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity. J Biol Chem (2009) 1.14

Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study. J Clin Oncol (2009) 1.06

TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells. Epigenetics (2014) 0.99

PDGF induced microRNA alterations in cancer cells. Nucleic Acids Res (2011) 0.97

Targeting angiogenesis in ovarian cancer. Cancer Treat Rev (2011) 0.93

Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism. FASEB J (2013) 0.91

Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase. Mol Cancer Ther (2011) 0.89

Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer. Neoplasia (2013) 0.88

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm study. Cancer (2013) 0.84

Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysis. Cancer (2010) 0.82

Use of enzymatic tools for biomonitoring inorganic pollution in aquatic sediments: a case study (Bor, Serbia). Chem Cent J (2013) 0.81

Power Doppler sonography, a non-invasive method of assessment of the synovial inflammation in patients with early rheumatoid arthritis. Rom J Morphol Embryol (2011) 0.81

Bleeding Dieulafoy's-like lesions of the gut identified by capsule endoscopy. World J Gastroenterol (2013) 0.80

[Evaluation of COPD patients using CAT-COPD assessment test]. Pneumologia (2013) 0.80

Numerical simulations of the 3D virtual model of the human hip joint, using finite element method. Rom J Morphol Embryol (2010) 0.79

Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer. Mol Cancer Ther (2012) 0.79

Macroscopic and microscopic findings in avascular necrosis of the femoral head. Rom J Morphol Embryol (2012) 0.79

Periarticular diffuse neurofibroma of the upper limb. Rom J Morphol Embryol (2011) 0.78

Pegylated liposomal doxorubicin in ovarian cancer. Ther Clin Risk Manag (2009) 0.78

[Clopidogrel resistance--risk factor in patients with acute coronary syndromes]. Rev Med Chir Soc Med Nat Iasi (2012) 0.77

Blockade of FGF signaling: therapeutic promise for ovarian cancer. Cancer Biol Ther (2010) 0.77

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer. Eur J Cancer (2012) 0.77

Phenotypic variability in Patau syndrome. Rev Med Chir Soc Med Nat Iasi (2013) 0.77

Global DNA methylation profiling technologies and the ovarian cancer methylome. Methods Mol Biol (2015) 0.76

Morphometric findings in avascular necrosis of the femoral head. Rom J Morphol Embryol (2012) 0.75

Evaluation of cardiac parameters using electrical impedance plethysmography. Rev Med Chir Soc Med Nat Iasi (2012) 0.75

The generation of the three-dimensional model of the human knee joint. Rom J Morphol Embryol (2005) 0.75

The arthroscopy-histological criterion link in endoscopic "repair" treatment of chondral and chondralbone lesions of the knee. Rom J Morphol Embryol (2007) 0.75

Hypothesis of microfractures by buckling theory of bone's trabeculas from vertebral bodies affected by osteoporosis. Rom J Morphol Embryol (2009) 0.75

Macrophage response in patients diagnosed with aseptic necrosis of the femoral head presenting different risk factors. Rom J Morphol Embryol (2015) 0.75

Unlucky charms at lunch. Newsweek (2007) 0.75

[On a case of unilateral hypertransparent lung (unilateral hyperlucent lung)]. Med Interna (Bucur) (1970) 0.75

Breast mass in a patient with ovarian cancer: a case report. J Reprod Med (2009) 0.75

A complex assessment of patients with knee osteoarthritis and Baker's cyst: observational study. Rom J Morphol Embryol (2013) 0.75

The virtual model of the prosthetic tibial components. Rom J Morphol Embryol (2006) 0.75

The significance of angiogenesis and tumoral proliferation in renal cell carcinoma. Rom J Morphol Embryol (2011) 0.75

[Improvement of genetic diagnostic strategy in velo-cardio-facial syndrome]. Rev Med Chir Soc Med Nat Iasi (2011) 0.75

BIOENERGETIC CHARACTERIZATION OF H9C2 CELLS USING THE EXTRACELLULAR FLUX ANALYZER. Rev Med Chir Soc Med Nat Iasi (2015) 0.75

The arthroscopy-histological criterion link in the result's estimation of the endoscopic treatment by resection of the knee's meniscus lesions. Rom J Morphol Embryol (2011) 0.75

[Lower limb varicosity in patients, with indication for total knee arthroplasty]. Chirurgia (Bucur) (2005) 0.75

Imaging and histopathological aspects in aseptic osteonecrosis of the femoral head. Rom J Morphol Embryol (2015) 0.75

[Dextrocardia of post right pneumonectomy]. Rev Med Chir Soc Med Nat Iasi (2009) 0.75

CAD method for three-dimensional model of the tibia bone and study of stresses using the finite element method. Rom J Morphol Embryol (2006) 0.75

Accidentally ingested foreign body associated with liver actinomycosis: the diagnostic value of imaging. J Gastrointestin Liver Dis (2013) 0.75

Impact of clopidogrel response on the clinical evolution in patients with acute coronary syndromes. Rev Med Chir Soc Med Nat Iasi (2013) 0.75

Multifactorial analysis of local and lymph node recurrences after conservative or radical surgery for stage 0-II breast cancer. Rev Med Chir Soc Med Nat Iasi (2015) 0.75

Histological study [correction of styudy] of the femural head and neck microscopic architecture in persons with senile osteoporosis. Rom J Morphol Embryol (2005) 0.75

Muscle metastases from cervical carcinoma - case report. Rom J Morphol Embryol (2017) 0.75

A guide to predicting your medical future. Newsweek (2008) 0.75

Histopathological and immunohistochemical aspects in chronic suppurative maxillary rhinosinusitis. Rom J Morphol Embryol (2011) 0.75

Numerical simulations of human tibia osteosynthesis using modular plates based on Nitinol staples. Rom J Morphol Embryol (2010) 0.75